<?xml version="1.0" encoding="UTF-8"?>
<ref id="R5">
 <label>5</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Qin</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yi</surname>
    <given-names>M</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4</article-title>. 
  <source>Mol Cancer</source>
  <year>2019</year>;
  <volume>18</volume>:
  <elocation-id>155</elocation-id>. 
  <pub-id pub-id-type="doi">10.1186/s12943-019-1091-2</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31690319?>
  <pub-id pub-id-type="pmid">31690319</pub-id>
 </mixed-citation>
</ref>
